Recital 5, Decision_act (EU) 2024/2797

In forcesince 31 Oct 2024

France has provided justifiable grounds in accordance with Article 52 for believing that dinitrogen oxide presents a serious risk to human health (adverse effects on the nervous system when inhaled). The number of intoxication cases notified to the National Agency for the Safety of Pharmaceutical and Health Products in France has doubled in one year from 254 in 2020 to 472 in 2021. There has been a threefold increase in the number of serious cases between 2020 (82 cases) and 2021 (265 cases). Moreover, 303 cases were reported to French poison centres in 2021 compared to 134 in 2020. The intoxications were mainly caused by the recreational misuse of dinitrogen oxide, usually involving young adults and in certain cases adolescents. Among the reported effects, neurological effects were most commonly reported as well as cardio-vascular and developmental effects. France also informed the Commission on 16 January 2024 that the substance was increasingly sold in higher quantities and bigger packages.